apaflurane has been researched along with albuterol in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (24.19) | 18.2507 |
| 2000's | 39 (62.90) | 29.6817 |
| 2010's | 8 (12.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, KM; Donnell, D; Ekholm, BP; Harrison, LI; Klinger, NM; McEwen, J; Porietis, I; Ward, S | 1 |
| Cline, AC; Ekholm, BP; Kleerup, EC; Tashkin, DP | 1 |
| Chang, SF; Cline, A; Cooper, KM; Ekholm, BP; Harrison, LI; Jacobson, JP; Morganroth, J; Nelson, JR; Wells, TM | 1 |
| Hammerbeck, DM; Miller, RL; Nogami-Itoh, M; Takeyama, K; Yakuo, I | 1 |
| Barry, PW; O'Callaghan, C | 1 |
| Bleecker, ER; Colice, GL; Ekholm, BP; Klinger, NM; Ramsdell, J; Slade, HB; Tinkelman, DG | 2 |
| Ayres, JG; Frost, CD; Holmes, WF; Ward, SM; Williams, DR | 1 |
| Bronsky, E; Colice, GL; Ekholm, BP; Klinger, NM | 1 |
| Colice, GL; Ekholm, BP; Klinger, NM; Ramsdell, JW | 1 |
| Banerji, D; Chervinsky, P; Jacobson, K; Kane, RE; Noonan, M; Uryniak, T | 1 |
| Banerji, D; Bernstein, D; Gross, G; Kane, RE; Welch, M | 1 |
| Parameswaran, K | 1 |
| Borgström, L | 1 |
| Colice, GL; Dockhorn, RJ; Ekholm, BP; Klinger, NM | 1 |
| Dickinson, PA; Seville, PC; Simons, C; Taylor, G | 1 |
| Boccuzzi, SJ; Roehm, JB; Wogen, J | 1 |
| Braunstein, G; Sharma, R | 1 |
| Cripps, A; Riebe, M; Schulze, M; Woodhouse, R | 1 |
| Baumgarten, CR; Dorow, P; Gebhardt, R; Kettner, J; Sykes, AP; Weber, HH | 1 |
| Popov, D; Salat, D; Sykes, AP | 1 |
| Colice, GL; Ekholm, BP; Klinger, NM; Shapiro, GS | 1 |
| Barnhart, F; Lumry, W; Murray, A; Noveck, R; Reisner, C; Vandermeer, A; Weinstein, S | 1 |
| Fowler, SJ; Griffiths, EA; Lipworth, BJ; Wilson, AM | 1 |
| Ashurst, IC; Chowdhry, BZ; Davies-Cutting, CJ; Michael, Y; Riley, T; Snowden, MJ | 1 |
| Cheng, YS; Fu, CS; Yazzie, D; Zhou, Y | 1 |
| Clark, AR; Dellamary, LA; Hall, G; Hirst, PH; Newman, SP; Pitcairn, GR; Shorr, J; Tarara, TE; Weers, JG | 1 |
| Batty, EP; Langley, SJ; Masterson, CM; Sykes, AP; Woodcock, A | 1 |
| Currie, GP; Fowler, SJ; Lipworth, BJ | 1 |
| Craig-McFeely, PM; Maier, WC; Shakir, SA; Soriano, JB; Wilton, LV | 1 |
| Badier, M; Dubus, JC; Guillot, C | 1 |
| Cohen, RM; Gross, G; Guy, H | 1 |
| Baitinger, L; Dorinsky, P; Greos, LS; Gross, G; Nelson, HS; Scott, C; Wolfe, JD | 1 |
| Diot, P; Khanjari, F; Koninck, JC; Lemarié, E; Magro, P | 1 |
| Baitinger, L; Condemi, JJ; Dorinsky, P; Ho, SY; House, K; Pearlman, DS; Peden, D; Scott, C; Weinstein, S; White, M | 1 |
| Cavanaugh, R; Crim, C; Holmes, M; Lee, B; Lincourt, W | 1 |
| Chopra, N; Jenkins, M; Kahl, L; Rimmer, M; Williams, M | 1 |
| Daley-Yates, P; De Silva, M; Handel, M; Kempsford, R; Mehta, R | 1 |
| Benissan, LB; Britto, IL; Peyron, ID; Tardieu, BZ | 1 |
| Dorinsky, P; Ellsworth, A; House, K; Nathan, RA; Rooklin, A; Schoaf, L; Scott, C | 1 |
| Avvakoumova, VI; Coppolo, DP; Doyle, CC; Mitchell, JP; Nagel, MW; Rau, JL; Wiersema, KJ | 1 |
| Carranza-Rosenzweig, J; Crim, C; Lincourt, WR; Locantore, NW; Sheth, K; Wasserman, RL | 1 |
| Ceruti, E; Crim, C; Kleha, JF; Maspero, JF; Mehta, R; Qaqundah, PY; Scott, CA; Sugerman, RW; Wu, W | 1 |
| Colice, GL; Hendeles, L; Meyer, RJ | 1 |
| Perrio, MJ; Shakir, SA; Wilton, LV | 1 |
| Al-Haydari, M; da Rocha, SR; Wu, L | 1 |
| Clark, NM; Dombkowski, KJ; Leo, HL | 1 |
| Marriott, C; Martin, GP; Murnane, D | 1 |
| Baumgartner, RA; Corren, J; Goodwin, E; Hanrahan, JP; McVicar, WK; Nair, P; Pleskow, WW; Tripp, K | 1 |
| Butt, AT; Kamat, D; Pansare, M | 1 |
| Clearie, K; Lipworth, BJ | 1 |
| Andersen, LB; Edin, HM; Ho, SY; Ortega, HG; Schoaf, L; Scott-Wilson, CA | 1 |
| Galyon, SW; Smith, TE; Templeton, LB | 1 |
| Davis, AM; Ellsworth, A; Goodman, B; Kaashmiri, M; Lincourt, WR; Shepard, J; Trivedi, R | 1 |
| Blair, J; Koppenhagen, F; McCabe, JC; Zeng, XM | 1 |
| Chand, R; Ketai, L; Kuehl, PJ; Leach, CL; McDonald, JD; Norenberg, JP | 1 |
| Boyd, BJ; Gaisford, S; Ooi, J; Traini, D; Young, PM | 1 |
| Barletta, B; Blake, DR; Cooper, DM; Leu, SY; Meinardi, S; Nussbaum, E; Radom-Aizik, S; Randhawa, I; Shin, HW; Yoonessi, L | 1 |
| Iverson, H; Kerwin, EM; Lepore, MS; Miller, DS; Shah, T; Taveras, H; Wayne, D | 1 |
| Bhargava, S; Bhattacharya, A; Gogtay, J; Purandare, S; Rebello, J; Singh, V; Talwar, D; Whig, J | 1 |
| Berlinski, A; Pennington, D | 1 |
1 review(s) available for apaflurane and albuterol
| Article | Year |
|---|---|
Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants.
Topics: Adrenergic beta-Agonists; Aerosol Propellants; Albuterol; Asthma; Atmosphere; Bronchodilator Agents; Chlorofluorocarbons; Equipment Design; Forced Expiratory Volume; Government Regulation; Heart Rate; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Ozone; United States | 2007 |
34 trial(s) available for apaflurane and albuterol
| Article | Year |
|---|---|
Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
Topics: Adolescent; Adult; Aerosol Propellants; Albuterol; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Forced Expiratory Flow Rates; Forced Expiratory Volume; Hemodynamics; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Nebulizers and Vaporizers; Potassium | 1995 |
Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Chlorofluorocarbons; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Single-Blind Method; Spirometry; Treatment Outcome | 1996 |
Systemic concentrations of salbutamol and HFA-134a after inhalation of salbutamol sulfate in a chlorofluorocarbon-free system.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aerosol Propellants; Albuterol; Chlorofluorocarbons, Methane; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Nebulizers and Vaporizers | 1996 |
Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aerosol Propellants; Age Factors; Aged; Albuterol; Area Under Curve; Asthma; Body Weight; Bronchodilator Agents; Chlorofluorocarbons; Double-Blind Method; Drug Tolerance; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Placebos; Racial Groups; Remission Induction; Sex Factors; Spirometry | 1998 |
Proventil HFA and ventolin have similar safety profiles during regular use.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aerosol Propellants; Aged; Albuterol; Asthma; Blood Cell Count; Blood Chemical Analysis; Blood Pressure; Bronchodilator Agents; Double-Blind Method; Headache; Heart Rate; Humans; Hydrocarbons, Fluorinated; Longitudinal Studies; Medical Records; Middle Aged; Peak Expiratory Flow Rate; Placebos; Respiratory Tract Infections; Rhinitis; Safety; Sleep Wake Disorders | 1998 |
Postmarketing surveillance study of a non-chlorofluorocarbon inhaler according to the safety assessment of marketed medicines guidelines.
Topics: Adult; Albuterol; Bronchodilator Agents; Chlorofluorocarbons; Consumer Product Safety; Female; Guidelines as Topic; Humans; Hydrocarbons, Fluorinated; Male; Nebulizers and Vaporizers; Product Surveillance, Postmarketing; Treatment Refusal; United Kingdom | 1998 |
Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
Topics: Adult; Aerosol Propellants; Albuterol; Asthma; Chlorofluorocarbons; Chlorofluorocarbons, Methane; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Nebulizers and Vaporizers | 1999 |
Safety of long-term treatment with HFA albuterol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aerosol Propellants; Aerosols; Albuterol; Asthma; Bronchodilator Agents; Chlorofluorocarbons; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male | 1999 |
Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aerosols; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Chlorofluorocarbons; Double-Blind Method; Drug Therapy, Combination; Forced Expiratory Volume; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Safety; Treatment Outcome; Triamcinolone Acetonide | 1999 |
A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Asthma; Bronchodilator Agents; Chlorofluorocarbons, Methane; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Peak Expiratory Flow Rate; Safety; Treatment Outcome; Triamcinolone Acetonide | 1999 |
Proventil HFA prevents exercise-induced bronchoconstriction in children.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchial Spasm; Child; Chlorofluorocarbons; Cross-Over Studies; Exercise; Female; Humans; Hydrocarbons, Fluorinated; Male; Single-Blind Method; Treatment Outcome | 1999 |
Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study Group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Aged, 80 and over; Albuterol; Asthma; Bronchodilator Agents; Chlorofluorocarbons; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Peak Expiratory Flow Rate; Therapeutic Equivalency; Treatment Outcome | 2000 |
Equivalence of salbutamol 200 microg four times daily propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Eastern European study group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Asthma; Bronchodilator Agents; Chlorofluorocarbons; Double-Blind Method; Female; Forced Expiratory Volume; Heart Rate; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Peak Expiratory Flow Rate; Therapeutic Equivalency; Treatment Outcome | 2000 |
Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma.
Topics: Aerosol Propellants; Albuterol; Asthma; Bronchodilator Agents; Child; Child, Preschool; Chlorofluorocarbons; Female; Humans; Hydrocarbons, Fluorinated; Male; Safety; Spirometry; Treatment Outcome | 2000 |
Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aerosol Propellants; Albuterol; Asthma; Bronchodilator Agents; Chlorofluorocarbons; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Patient Compliance | 2001 |
Comparative in vivo lung delivery of hydrofluoroalkane-salbutamol formulation via metered-dose inhaler alone, with plastic spacer, or with cardboard tube.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Biological Availability; Bronchodilator Agents; Chromatography, High Pressure Liquid; Cross-Over Studies; Equipment Design; Humans; Hydrocarbons, Fluorinated; Lung; Middle Aged; Nebulizers and Vaporizers; Single-Blind Method | 2001 |
In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler.
Topics: Adult; Albuterol; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Delivery Systems; Female; Humans; Hydrocarbons, Fluorinated; Lung; Male; Microspheres; Middle Aged; Nebulizers and Vaporizers; Porosity; Statistics, Nonparametric | 2002 |
A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Albuterol; Asthma; Bronchodilator Agents; Chlorofluorocarbons; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Headache; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Time Factors; Tremor | 2002 |
Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchial Provocation Tests; Bronchodilator Agents; Drug Administration Schedule; Drug Therapy, Combination; Fluticasone; Humans; Hydrocarbons, Fluorinated; Middle Aged; Outcome Assessment, Health Care; Quality of Life; Respiratory Function Tests; Salmeterol Xinafoate | 2002 |
Electrostatic charge on spacer devices and salbutamol response in young children.
Topics: Administration, Inhalation; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Child; Child, Preschool; Female; Humans; Hydrocarbons, Fluorinated; Inhalation Spacers; Male; Methacholine Chloride; Static Electricity | 2003 |
Efficacy response of inhaled HFA-albuterol delivered via the breath-actuated Autohaler inhalation device is comparable to dose in patients with asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Treatment Outcome | 2003 |
Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child; Drug Therapy, Combination; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Salmeterol Xinafoate; Time Factors; Treatment Outcome | 2003 |
Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
Topics: Adolescent; Adult; Aerosol Propellants; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Inflammatory Agents; Area Under Curve; Asthma; Child; Chlorofluorocarbons; Double-Blind Method; Drug Combinations; Female; Fluticasone-Salmeterol Drug Combination; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Respiratory Function Tests | 2004 |
Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
Topics: Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Chemical Phenomena; Chemistry, Physical; Child; Child, Preschool; Chlorofluorocarbons; Circadian Rhythm; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Treatment Outcome | 2005 |
Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects.
Topics: Adolescent; Adult; Aerosol Propellants; Albuterol; Anti-Asthmatic Agents; Asthma; Chemical Phenomena; Chemistry, Physical; Chlorofluorocarbons; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Potassium; Salmeterol Xinafoate | 2005 |
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Topics: Adolescent; Adult; Aerosol Propellants; Aged; Aged, 80 and over; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Drug Administration Schedule; Female; Fluticasone; Follow-Up Studies; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Salmeterol Xinafoate; Spirometry; Time Factors; Treatment Outcome | 2006 |
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Patient Satisfaction; Powders; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Treatment Outcome | 2006 |
Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child, Preschool; Circadian Rhythm; Double-Blind Method; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Infant; Male; Metered Dose Inhalers; Treatment Outcome | 2006 |
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Heart Rate; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Spirometry | 2008 |
Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Topics: Administration, Inhalation; Adult; Aerosol Propellants; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Quality of Life; Salmeterol Xinafoate; Surveys and Questionnaires; Treatment Outcome; United States | 2009 |
Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydrocarbons, Fluorinated; Infant; Infant, Newborn; Lung Diseases, Obstructive; Male; Masks; Metered Dose Inhalers; Respiratory Sounds; Time Factors; Treatment Outcome | 2010 |
Quantification of Aerosol Hydrofluoroalkane HFA-134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aerosol Propellants; Aerosols; Albuterol; Breath Tests; Bronchodilator Agents; California; Chemistry, Pharmaceutical; Drug Monitoring; Exhalation; Female; Fluticasone; Forced Expiratory Volume; Healthy Volunteers; Humans; Hydrocarbons, Fluorinated; Male; Maximal Midexpiratory Flow Rate; Medication Adherence; Middle Aged; Predictive Value of Tests; Vital Capacity | 2015 |
Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
Topics: Administration, Inhalation; Adult; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Dry Powder Inhalers; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Respiratory Function Tests; Young Adult | 2016 |
Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Aerosol Propellants; Aged; Albuterol; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Equipment Design; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; India; Ipratropium; Lung; Male; Metered Dose Inhalers; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Therapeutic Equivalency; Time Factors; Treatment Outcome | 2016 |
27 other study(ies) available for apaflurane and albuterol
| Article | Year |
|---|---|
The equivalent bronchodilator effects of salbutamol formulated in chlorofluorocarbon and hydrofluoroalkane-134a metered dose inhalers on the histamine-induced pulmonary response in dogs.
Topics: Albuterol; Animals; Blood Pressure; Bronchoconstriction; Bronchodilator Agents; Chlorofluorocarbons; Dogs; Heart Rate; Histamine; Hydrocarbons, Fluorinated; Male; Nebulizers and Vaporizers; Therapeutic Equivalency | 1997 |
In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Chemistry, Pharmaceutical; Hydrocarbons, Fluorinated; Nebulizers and Vaporizers; Particle Size | 1997 |
Concepts of establishing clinical bioequivalence of chlorofluorocarbon and hydrofluoroalkane beta-agonists.
Topics: Adrenergic beta-Agonists; Aerosol Propellants; Albuterol; Bronchodilator Agents; Chlorofluorocarbons; Humans; Hydrocarbons, Fluorinated; Nebulizers and Vaporizers; Therapeutic Equivalency | 1999 |
The pharmacokinetics of inhaled hydrofluoroalkane formulations.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Beclomethasone; Chemistry, Pharmaceutical; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Lung; Radionuclide Imaging | 1999 |
Prodrug to probe solution HFA pMDI formulation and pulmonary esterase activity.
Topics: Aerosol Propellants; Albuterol; Animals; Bronchodilator Agents; Cells, Cultured; Chemistry, Pharmaceutical; Esterases; Hydrocarbons, Fluorinated; Hydrolysis; Lung; Male; Nebulizers and Vaporizers; Prodrugs; Rats; Rats, Wistar; Solubility | 2000 |
Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Asthma; Bronchodilator Agents; Child; Child, Preschool; Chlorofluorocarbons; Cohort Studies; Female; Humans; Hydrocarbons, Fluorinated; Infant; Male; Middle Aged; Nebulizers and Vaporizers | 2000 |
The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Chlorofluorocarbons; Fluticasone; Humans; Hydrocarbons, Fluorinated; Nebulizers and Vaporizers | 2000 |
Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
Topics: Aerosol Propellants; Albuterol; Androstadienes; Anti-Asthmatic Agents; Bronchodilator Agents; Fluticasone; Humans; Hydrocarbons, Fluorinated; Nebulizers and Vaporizers; Particle Size | 2000 |
Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system.
Topics: Administration, Inhalation; Aerosols; Albuterol; Androstadienes; Anti-Asthmatic Agents; Chemistry, Pharmaceutical; Chlorofluorocarbons, Ethane; Chlorofluorocarbons, Methane; Drug Interactions; Fluticasone; Hydrocarbons, Fluorinated; Salmeterol Xinafoate | 2001 |
Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
Topics: Administration, Inhalation; Adult; Aerosols; Albuterol; Bronchodilator Agents; Chemistry, Pharmaceutical; Chlorofluorocarbons; Drug Evaluation, Preclinical; Humans; Hydrocarbons, Fluorinated; Lung; Male; Models, Anatomic; Nebulizers and Vaporizers; Oropharynx; Particle Size; Radionuclide Imaging; Technetium; Tissue Distribution | 2001 |
Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA134a in England.
Topics: Albuterol; Asthma; Chemistry, Pharmaceutical; Child; England; Female; Humans; Hydrocarbons, Fluorinated; Male; Prospective Studies; Severity of Illness Index | 2003 |
HFA inhalers.
Topics: Aerosol Propellants; Albuterol; Asthma; Beclomethasone; Bronchodilator Agents; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic | 2004 |
Evaluation of particle size distribution of albuterol sulfate hydrofluoroalkane administered via metered-dose inhaler with and without valved holding chambers.
Topics: Albuterol; Asthma; Bronchodilator Agents; Child, Preschool; Humans; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Particle Size | 2005 |
Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Anti-Asthmatic Agents; Chemical Phenomena; Chemistry, Physical; Chlorofluorocarbons; Drug Administration Schedule; Equipment Design; Humans; Hydrocarbons, Fluorinated; Materials Testing; Metered Dose Inhalers; Particle Size; Reproducibility of Results; Salmeterol Xinafoate | 2005 |
The importance of nonelectrostatic materials in holding chambers for delivery of hydrofluoroalkane albuterol.
Topics: Aerosol Propellants; Albuterol; Drug Delivery Systems; Equipment Failure; Humans; Hydrocarbons, Fluorinated; Ontario; Product Packaging; Static Electricity | 2006 |
A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance.
Topics: Adult; Aerosol Propellants; Aged; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Drug Combinations; England; Female; Fluticasone-Salmeterol Drug Combination; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Pregnancy; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive | 2007 |
Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
Topics: Acetates; Administration, Inhalation; Aerosol Propellants; Albuterol; Diffusion; Drug Stability; Emulsifying Agents; Emulsions; Excipients; Hydrocarbons, Fluorinated; Lecithins; Magnetic Resonance Spectroscopy; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Pharmaceutical Preparations; Polyethylene Glycols; Surface Tension; Technology, Pharmaceutical; Terbutaline; X-Ray Diffraction | 2008 |
The economic effect of the hydrofluoroalkane albuterol transition on children with asthma.
Topics: Albuterol; Asthma; Bronchodilator Agents; Child; Humans; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Poverty | 2008 |
Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
Topics: Administration, Inhalation; Aerosol Propellants; Aerosols; Albuterol; Androstadienes; Bronchodilator Agents; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Fluticasone; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Particle Size; Polyethylene Glycols; Pressure; Reproducibility of Results; Salmeterol Xinafoate; Technology, Pharmaceutical | 2008 |
Final count down to hfa albuterol inhalers: are we ready as yet?
Topics: Albuterol; Asthma; Bronchodilator Agents; Chlorofluorocarbons; Humans; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Ozone; Patient Education as Topic; United States; United States Food and Drug Administration | 2009 |
Levalbuterol kinetics.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Heart Rate; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Spirometry | 2009 |
A switch to eco-friendly inhalers.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Bronchodilator Agents; Green Chemistry Technology; Humans; Hydrocarbons, Fluorinated; Metered Dose Inhalers | 2009 |
Overcoming dose-counting mechanisms on metered-dose inhalers for urgent treatment in the operating room.
Topics: Administration, Inhalation; Adolescent; Aerosol Propellants; Albuterol; Bronchial Spasm; Bronchodilator Agents; Equipment Design; Female; Humans; Hydrocarbons, Fluorinated; Intraoperative Care; Metered Dose Inhalers; Procaterol | 2009 |
ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
Topics: Albuterol; Asthma; Bronchodilator Agents; Equipment Design; Humans; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Particle Size; Temperature; Time Factors | 2012 |
Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Cross-Over Studies; Drug Combinations; Fluticasone-Salmeterol Drug Combination; Humans; Hydrocarbons, Fluorinated; Lung; Particle Size; Radionuclide Imaging | 2012 |
Isothermal calorimetry: a predictive tool to model drug-propellant interactions in pressurized metered dose systems.
Topics: Aerosol Propellants; Albuterol; Beclomethasone; Calorimetry; Chemistry, Pharmaceutical; Crystallization; Fluorocarbons; Hydrocarbons, Fluorinated; Metered Dose Inhalers | 2014 |
Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Drug Administration Schedule; Drug Delivery Systems; Humans; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Procaterol; Time Factors | 2017 |